TY - JOUR
T1 - Airway management during transoral robotic surgery for head and neck cancers
T2 - a French GETTEC group survey
AU - Poissonnet, Valentine
AU - Chabrillac, Emilien
AU - Schultz, Philippe
AU - Morinière, Sylvain
AU - Gorphe, Philippe
AU - Baujat, Bertrand
AU - Garrel, Renaud
AU - Lasne-Cardon, Audrey
AU - Villeneuve, Alexandre
AU - Chambon, Guillaume
AU - Fakhry, Nicolas
AU - Aubry, Karine
AU - Dufour, Xavier
AU - Malard, Olivier
AU - Mastronicola, Romina
AU - Vairel, Benjamin
AU - Gallet, Patrice
AU - Ceruse, Philippe
AU - Jegoux, Franck
AU - Ton Van, Jean
AU - De Bonnecaze, Guillaume
AU - Vergez, Sébastien
N1 - Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2022/7/1
Y1 - 2022/7/1
N2 - Purpose: The aim of the survey was to define the indications for preventive tracheostomy in transoral robotic surgery (TORS) for head and neck cancers. Methods: From October 2019 to January 2020, an online questionnaire was e-mailed to French surgical ENT teams with considerable experience of the TORS procedure (Gettec group). A descriptive analysis of the answers was performed. Results: Eighteen French surgical teams answered the questionnaire. For 77.8% of the surgical teams, a past history of radiotherapy with residual edema was an indication for prophylactic tracheostomy, and for 88.9%, > 75 mg of antiplatelet medication or anticoagulation treatment was an indication. Conclusion: Early preventive tracheostomy during TORS can protect airway from uncommon but potentially life-threatening complications, such as transoral hemorrhage or airway edema. We recommend it in high-risk situations, such as a past history of radiotherapy or antiplatelet therapy associated with large resections. Further studies are needed to establish evidence-based recommendations.
AB - Purpose: The aim of the survey was to define the indications for preventive tracheostomy in transoral robotic surgery (TORS) for head and neck cancers. Methods: From October 2019 to January 2020, an online questionnaire was e-mailed to French surgical ENT teams with considerable experience of the TORS procedure (Gettec group). A descriptive analysis of the answers was performed. Results: Eighteen French surgical teams answered the questionnaire. For 77.8% of the surgical teams, a past history of radiotherapy with residual edema was an indication for prophylactic tracheostomy, and for 88.9%, > 75 mg of antiplatelet medication or anticoagulation treatment was an indication. Conclusion: Early preventive tracheostomy during TORS can protect airway from uncommon but potentially life-threatening complications, such as transoral hemorrhage or airway edema. We recommend it in high-risk situations, such as a past history of radiotherapy or antiplatelet therapy associated with large resections. Further studies are needed to establish evidence-based recommendations.
KW - Airway management
KW - Head and neck cancer
KW - Tracheostomy
KW - Transoral robotic surgery
UR - http://www.scopus.com/inward/record.url?scp=85123471930&partnerID=8YFLogxK
U2 - 10.1007/s00405-021-07188-4
DO - 10.1007/s00405-021-07188-4
M3 - Article
C2 - 35066651
AN - SCOPUS:85123471930
SN - 0937-4477
VL - 279
SP - 3619
EP - 3627
JO - European Archives of Oto-Rhino-Laryngology
JF - European Archives of Oto-Rhino-Laryngology
IS - 7
ER -